{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:46:39Z","timestamp":1791524799506,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.rdc.2021.07.002","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T07:16:04Z","timestamp":1629530164000},"page":"725-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Juvenile Fibromyalgia"],"prefix":"10.1016","volume":"47","author":[{"given":"Jennifer E.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Kashikar-Zuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.1780280205","article-title":"Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls","volume":"28","author":"Yunus","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrrheum.2013.177","article-title":"Juvenile fibromyalgia: current status of research and future developments","volume":"10","author":"Kashikar-Zuck","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2021.07.002_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","article-title":"Neurobiology of fibromyalgia and chronic widespread pain","volume":"338","author":"Sluka","year":"2016","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.rdc.2021.07.002_bib5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jpepsy\/jsq020","article-title":"Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia","volume":"35","author":"Kashikar-Zuck","year":"2010","journal-title":"J\u00a0Pediatr Psychol"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.002_bib6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/art.24099","article-title":"Family factors, emotional functioning, and functional impairment in juvenile fibromyalgia syndrome","volume":"59","author":"Kashikar-Zuck","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.002_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/AJP.0b013e31816d7d23","article-title":"Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome","volume":"24","author":"Kashikar-Zuck","year":"2008","journal-title":"Clin J Pain"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.002_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib9","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1542\/peds.2013-2220","article-title":"Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood","volume":"133","author":"Kashikar-Zuck","year":"2014","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.rdc.2021.07.002_bib10","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/rheumatology\/keq254","article-title":"Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome","volume":"49","author":"Kashikar-Zuck","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.002_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.mpg.0000338962.17185.18","article-title":"Amplified musculoskeletal pain: treatment approach and outcomes","volume":"47","author":"Sherry","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.002_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.002_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"65","author":"Wolfe","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.002_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00002281-199609000-00010","article-title":"Epidemiology of rheumatic disease in children","volume":"8","author":"Gare","year":"1996","journal-title":"Curr Opin Rheumatol"},{"issue":"3 Pt 1","key":"10.1016\/j.rdc.2021.07.002_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1542\/peds.101.3.377","article-title":"Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up","volume":"101","author":"Siegel","year":"1998","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib16","first-page":"368","article-title":"Assessment of nonarticular tenderness and prevalence of fibromyalgia in children","volume":"20","author":"Buskila","year":"1993","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2021.07.002_bib17","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.pain.2011.07.016","article-title":"The epidemiology of chronic pain in children and adolescents revisited: a systematic review","volume":"152","author":"King","year":"2011","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12969-019-0356-z","article-title":"Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry","volume":"17","author":"Weiss","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.002_bib19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","article-title":"Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia","volume":"46","author":"Gracely","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.002_bib20","first-page":"438","article-title":"The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample","volume":"14","author":"Neblett","year":"2013","journal-title":"J\u00a0Pain"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.002_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/ern.12.41","article-title":"Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions","volume":"12","author":"Staud","year":"2012","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/j.pain.0000000000000707","article-title":"Towards a neurophysiological signature for fibromyalgia","volume":"158","author":"Lopez-Sola","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.rdc.2021.07.002_bib23","unstructured":"Su\u00f1ol M, PM, Tong H, et\u00a0al. Brain Structural Correlates of Juvenile Fibromyalgia. Poster presented at: IASP 2021 Virtual World Congress on Pain. June 9-11 and 16-18, 2021. Available at: https:\/\/iaspvirtualcongress.evareg.com\/poster\/brain-structural-correlates-of-juvenile-fibromyalgia. Accessed July 29, 2021."},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.20042","article-title":"Family study of fibromyalgia","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib25","first-page":"579","article-title":"Juvenile fibromyalgia: clinical and polysomnographic aspects","volume":"24","author":"Roizenblatt","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.berh.2015.04.018","article-title":"Update on the genetics of the fibromyalgia syndrome","volume":"29","author":"Ablin","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2217\/14622416.8.1.67","article-title":"The genetics of fibromyalgia syndrome","volume":"8","author":"Buskila","year":"2007","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.002_bib28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrrheum.2013.43","article-title":"The phenotypic and genetic signatures of common musculoskeletal pain conditions","volume":"9","author":"Diatchenko","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.autrev.2008.07.023","article-title":"Etiology of fibromyalgia: the possible role of infection and vaccination","volume":"8","author":"Buskila","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib30","first-page":"101","article-title":"Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision","volume":"12","author":"McLean","year":"2011","journal-title":"J\u00a0Pain"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.002_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3899\/jrheum.200378","article-title":"Epidermal neurite density in skin biopsies from patients with juvenile fibromyalgia","volume":"48","author":"Boneparth","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.002_bib32","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1542\/peds.2012-2597","article-title":"Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes","volume":"131","author":"Oaklander","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib33","first-page":"525","article-title":"Fibromyalgia syndrome in children--an outcome study","volume":"22","author":"Buskila","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib34","first-page":"674","article-title":"One year outcome of preadolescents with fibromyalgia","volume":"26","author":"Mikkelsson","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/j.pain.0000000000001415","article-title":"Long-term outcomes of adolescents with juvenile-onset fibromyalgia into adulthood and impact of depressive symptoms on functioning over time","volume":"160","author":"Kashikar-Zuck","year":"2019","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2021.07.002_bib37","first-page":"146","article-title":"Pain symptomatology and management in pediatric Ehlers-Danlos syndrome: a review","volume":"7","author":"Feldman","year":"2020","journal-title":"Children (Basel)"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.002_bib38","first-page":"1777","article-title":"The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS)","volume":"27","author":"Grahame","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/adc.80.2.188","article-title":"Joint hypermobility and genetic collagen disorders: are they related?","volume":"80","author":"Grahame","year":"1999","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12969-020-00487-w","article-title":"Suicidal risk and resilience in juvenile fibromyalgia syndrome: a cross-sectional cohort study","volume":"19","author":"Gmuca","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.002_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40272-017-0233-5","article-title":"Fibromyalgia: treating pain in the juvenile patient","volume":"19","author":"Gmuca","year":"2017","journal-title":"Paediatr Drugs"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2021.07.002_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpeds.2015.10.011","article-title":"2010 American College of Rheumatology adult fibromyalgia criteria for use in an adolescent female population with juvenile fibromyalgia","volume":"169","author":"Ting","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2021.07.002_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/acr.24197","article-title":"Measures of juvenile fibromyalgia","volume":"72","author":"Daffin","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.rdc.2021.07.002_bib45","first-page":"1049","article-title":"Pilot randomized trial of integrated cognitive-behavioral therapy and neuromuscular training for juvenile fibromyalgia: the FIT Teens Program","volume":"19","author":"Kashikar-Zuck","year":"2018","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.rdc.2021.07.002_bib46","doi-asserted-by":"crossref","first-page":"106321","DOI":"10.1016\/j.cct.2021.106321","article-title":"Randomized clinical trial of Fibromyalgia Integrative Training (FIT teens) for adolescents with juvenile fibromyalgia - study design and protocol","volume":"103","author":"Kashikar-Zuck","year":"2021","journal-title":"Contemp Clin Trials"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.002_bib47","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.pain.2014.06.008","article-title":"Differential changes in functional disability and pain intensity over the course of psychological treatment for children with chronic pain","volume":"155","author":"Lynch-Jordan","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.rdc.2021.07.002_bib48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2016.12.053","article-title":"Mindfulness-based stress reduction for adolescents with functional somatic syndromes: a pilot cohort study","volume":"183","author":"Ali","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.30644","article-title":"Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial","volume":"64","author":"Kashikar-Zuck","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00002508-199909000-00009","article-title":"Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy","volume":"15","author":"Sherry","year":"1999","journal-title":"Clin J pain"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.002_bib51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.pcl.2018.04.004","article-title":"Pediatric pain syndromes and noninflammatory musculoskeletal pain","volume":"65","author":"Weiss","year":"2018","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.002_bib52","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jpepsy\/jsj064","article-title":"Development and evaluation of a cognitive-behavioral intervention for juvenile fibromyalgia","volume":"31","author":"Degotardi","year":"2006","journal-title":"J\u00a0Pediatr Psychol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.002_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/acr.22946","article-title":"Preliminary outcomes of a cross-site cognitive-behavioral and neuromuscular integrative training intervention for juvenile fibromyalgia","volume":"69","author":"Tran","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/pch\/12.2.95","article-title":"Why were we abandoned? Orphan drugs in paediatric pain","volume":"12","author":"Gr\u00e9goire","year":"2007","journal-title":"Paediatrics Child Health"},{"key":"10.1016\/j.rdc.2021.07.002_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-015-0025-9","article-title":"Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program","volume":"13","author":"Arnold","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/JCP.0b013e31824858dc","article-title":"An exploratory, open trial of fluoxetine treatment of juvenile fibromyalgia","volume":"32","author":"Mariutto","year":"2012","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-019-0325-6","article-title":"Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial","volume":"17","author":"Upadhyaya","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.002_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-016-0106-4","article-title":"Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study","volume":"14","author":"Arnold","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.002_bib59","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1503\/cmaj.1041507","article-title":"FDA urges \"black box\" warning on pediatric antidepressants","volume":"171","author":"Kondro","year":"2004","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.002_bib60","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.pcl.2005.01.003","article-title":"Pediatric pain syndromes and management of pain in children and adolescents with rheumatic disease","volume":"52","author":"Anthony","year":"2005","journal-title":"Pediatr Clin North Am"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21010966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21010966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:21:36Z","timestamp":1760181696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X21010966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0889857X21010966"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile Fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}